Sort
40,608 grants matching “prostate cancer”
SYNTHETIC SUBSTANCES CONTROLLING REPRODUCTION
$334,440Salk Institute For Biological Studies · R01 · FY2001 · HD
SYNTHETIC SUBSTANCES CONTROLLING REPRODUCTION
$334,440Salk Institute For Biological Studies · R01 · FY2004 · HD
SYNTHETIC SUBSTANCES CONTROLLING REPRODUCTION
$334,440Salk Institute For Biological Studies · R01 · FY2003 · HD
SYNTHETIC SUBSTANCES CONTROLLING REPRODUCTION
$334,440Salk Institute For Biological Studies · R01 · FY2005 · HD
SYNTHETIC SUBSTANCES CONTROLLING REPRODUCTION
$334,440Salk Institute For Biological Studies · R01 · FY2002 · HD
The Molecular Profile of Prostate Tumors in African-American Men
$334,423Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Artificial Intelligence Driven Automatic Treatment Planning of Stereotactic Radiosurgery for the Management of Multiple Brain Metastases
$334,416Zhen Tian · University Of Chicago · R37 · FY2023 · CA
PET Proliferation Tracers
$334,415Jeffrey L Schwartz · University Of Washington · R01 · FY2008 · CA
The Interplay Between Sleep, Melatonin, and Mortality in Older Men
$334,406Eva S Schernhammer · Brigham And Women'S Hospital · R01 · FY2010 · AG
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo
$334,400Victoria Perepelitsa Belancio · Tulane University Of Louisiana · R01 · FY2021 · AG
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo
$334,400Victoria Perepelitsa Belancio · Tulane University Of Louisiana · R01 · FY2022 · AG
Transgenic Mice as Models for Antivascular Therapy
$334,388William M Lee · University Of Pennsylvania · R01 · FY2007 · CA
WUMC-Cancer and Leukemia Group B
$334,381Nancy L Bartlett · Washington University · U10 · FY2007 · CA
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo
$334,308Victoria Perepelitsa Belancio · Tulane University Of Louisiana · R01 · FY2020 · AG
ROLE OF THE ARF TUMOR SUPPRESSOR IN PROSTATE CANCER
$334,270Washington University, The · · FY2009 · Department of Defense
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
$334,226Daniel Nomura · University Of California Berkeley · R01 · FY2015 · CA
ROLE OF NKX3.1 IN PROSTATE DEVELOPMENT AND CANCER
$334,201Washington University · R01 · FY2002 · CA
Obesogenic environment: impact on breast, colorectal, and prostate cancer risk
$334,144Iona C Cheng · Cancer Prevention Instit Of California · R01 · FY2014 · CA
Delineating racially distinct metabolic pathways in triple negative breast cancer
$334,143Arun Sreekumar · Baylor College Of Medicine · U01 · FY2017 · CA
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance
$334,133Lorelei Mucci · Dana-Farber Cancer Inst · P50 · FY2015 · CA
NOVEL CYTOTOXIC NATURAL PRODUCTS FROM MARINE SPONGES
$334,127University Of California Santa Cruz · R01 · FY2000 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER
$334,125University Of Maryland Baltimore · R01 · FY2005 · CA
RES FACIL IMPROVEMENT: CANCER: BREAST, PROSTATE, SKIN, GLIOMA
$334,125University Of Alabama At Birmingham · C06 · FY2004 · RR
Drug Development of Ribonucleotide Reductase Inhibitor
$334,117Yun Yen · Beckman Research Institute/City Of Hope · R01 · FY2011 · CA
Drug Development of Ribonucleotide Reductase Inhibitor
$334,117David A. Horne · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA